EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 9

Sea buckthorn Hippophae rhamnoides L.

Also called: sea-buckthorn, Hippophaë rhamnoides, Elaeagnus rhamnoides (synonym)

Sea buckthorn is a plant whose berries yield juice, pulp oil and seed oil. Ingredients notified to FDA and products tested in trials include seed and fruit oils, whole berries, juice, powders and leaf extracts.

Category
Botanical
Part used
Berries (fruit pulp oil, seed oil, juice, powder); leaves
Strongest evidence
B Some positive trials
Native range
Native from Europe to southern Siberia and south-central China (POWO: "Europe to S. Siberia and SC. China")
Reviewed
2026-10-29

Class 2 Moderately studied in people. This entry cites 4 RCTs of sea buckthorn alone: source [4] (oil, dry eye; source [1] reports the same trial), source [5] (oil), source [6] (berries) and source [7] (oil capsules). A 2022 meta-analysis (source [3]) pooled 15 RCTs; whether all tested sea buckthorn alone could not be confirmed. [4]

Fact-checked 2026-10-29 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

5 topics studied4 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Sea buckthorn does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Sea buckthorn, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Blood lipids in adultsBA meta-analysis of 15 RCTs found lower triglycerides, total and LDL cholesterol and higher HDL; subgroup analysis showed lipid reductions only in people with abnormal lipids. Heterogeneity was high. [3]
Blood glucose, blood pressure and BMICThe 2022 Geng meta-analysis of 15 RCTs found no effect on blood sugar, blood pressure or body mass index. [3]
Dry eye symptomsCIn an RCT (100 adults, 86 completed), 2 g/day sea buckthorn oil for 3 months limited the cold-season rise in tear osmolarity versus placebo and lowered some symptom intensities. [4]
Vaginal atrophy after menopauseCIn an RCT of 116 postmenopausal women, 3 g/day oil for 3 months improved vaginal epithelial integrity versus placebo (OR 3.1); the vaginal health index showed only a trend. [5]
Common colds and digestive infections in healthy adultsCIn an RCT of 254 healthy adults, sea buckthorn berries did not change the number or duration of colds or digestive tract infections; serum CRP decreased slightly versus placebo. [6]

Main constituents: Sea buckthorn oil containing linoleic and alpha-linolenic acids; carotenoids and tocopherols in the oil are discussed as possible contributors to its effects [1]; Carotenoids (total 53-97 mg/100 g dry weight in berries of six varieties), mainly as di-esters, with zeaxanthin di-palmitate the major compound [2]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • Studied in a trial: 2 g/day sea buckthorn oil for 3 months (dry eye). [4]
  • Studied in a trial: 3 g/day sea buckthorn oil for 3 months (postmenopausal vaginal atrophy). [5]
  • Studied in a trial: 4 capsules daily, each with 500 mg sea buckthorn oil, for 8 weeks (hemodialysis patients). [7]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Interactions with medicines
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    17 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • In 45 hemodialysis patients taking sea buckthorn oil for 8 weeks, plasma phosphate and sodium increased and plasma iron decreased; there was no effect on oral health or inflammation. [7]
Quality

Identity, quality and standardization

  • Carotenoid profiles have been proposed as biomarkers for authenticity recognition of Carpathian sea buckthorn. [2]
Regulation

Regulatory status

  • US: FDA states that under DSHEA it does not have the authority to approve dietary supplements before they are marketed; firms are responsible for safety and labeling, and an NDI notification is required for certain new dietary ingredients. [8]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Linoleic and alpha-linolenic acids Fatty acids (oil) [P1]
  • Carotenoids (zeaxanthin di-palmitate major in berries; lutein and beta-carotene in leaves) Carotenoids [P2]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 17 entries naming sea buckthorn (Hippophae rhamnoides) (earliest NDI 251 submitted 2003-09-04; most recent NDI 923 submitted 2016-04-21). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. The entries cover seed oil, fruit oil, juice, granules, leaf and berry extracts, and seed powders. [P3]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of sea buckthorn (Hippophae rhamnoides) was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P4]
  • NTP technical reports list checked: no report on sea buckthorn. [P5]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • No published information found in the sources checked.

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test or examination of each component that is a dietary ingredient — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petition under (a)(1)(ii). [P6]

Supply and conservation

  • IUCN Red List: Least Concern (LC), via GBIF species API, retrieved 2026-10-29 (record for Hippophae rhamnoides L.). [P7]

Absorption in people

  • No published information found in the sources checked.

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • No published information found in the sources checked.

Sources for this profile

  1. Järvinen RL, et al. Effects of oral sea buckthorn oil on tear film fatty acids in individuals with dry eye. Cornea 2011;30(9):1013-9 (PMID 21832964), 2011-09. pubmed.ncbi.nlm.nih.gov
  2. Pop RM, et al. Carotenoid composition of berries and leaves from six Romanian sea buckthorn (Hippophae rhamnoides L.) varieties. Food Chem 2014;147:1-9 (PMID 24206678), 2014-03-15. pubmed.ncbi.nlm.nih.gov
  3. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  4. IARC Monographs. List of Classifications (1,060 agents, Volumes 1-142; checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
  5. National Toxicology Program (NIEHS). Technical Reports series list (607 reports; checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
  6. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  7. GBIF species API: IUCN Red List category for Hippophae rhamnoides L., 2026-10-29. api.gbif.org
Sources

Sources

  1. Järvinen RL, et al. Effects of oral sea buckthorn oil on tear film fatty acids in individuals with dry eye. Cornea 2011;30(9):1013-9 (PMID 21832964), 2011-09. pubmed.ncbi.nlm.nih.gov
  2. Pop RM, et al. Carotenoid composition of berries and leaves from six Romanian sea buckthorn (Hippophae rhamnoides L.) varieties. Food Chem 2014;147:1-9 (PMID 24206678), 2014-03-15. pubmed.ncbi.nlm.nih.gov
  3. Geng Y, et al. Effects of sea buckthorn (Hippophae rhamnoides L.) on factors related to metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. Phytother Res 2022;36(11):4101-4114 (PMID 36043374), 2022-11. pubmed.ncbi.nlm.nih.gov
  4. Larmo PS, et al. Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye. J Nutr 2010;140(8):1462-8 (PMID 20554904), 2010-08. pubmed.ncbi.nlm.nih.gov
  5. Larmo PS, et al. Effects of sea buckthorn oil intake on vaginal atrophy in postmenopausal women: a randomized, double-blind, placebo-controlled study. Maturitas 2014;79(3):316-21 (PMID 25104582), 2014-11. pubmed.ncbi.nlm.nih.gov
  6. Larmo P, et al. Effects of sea buckthorn berries on infections and inflammation: a double-blind, randomized, placebo-controlled trial. Eur J Clin Nutr 2008;62(9):1123-30 (PMID 17593932), 2008-09. pubmed.ncbi.nlm.nih.gov
  7. Rodhe Y, et al. The effect of sea buckthorn supplement on oral health, inflammation, and DNA damage in hemodialysis patients: a double-blinded, randomized crossover study. J Ren Nutr 2013;23(3):172-9 (PMID 23131570), 2013-05. pubmed.ncbi.nlm.nih.gov
  8. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
  9. Plants of the World Online (POWO), Royal Botanic Gardens, Kew. Hippophae rhamnoides L.: accepted name and native range as recorded in WCVP, the taxonomic index of POWO (WCVP Darwin Core archive, GBIF dataset f382f0ce-323a-4091-bb9f-add557f3a9a2, published 2026-06-04; read 2026-10-29), 2026-06-04. powo.science.kew.org
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.